Although previous reports showing that metformin protects against hypertension and kidney disease via AMPK activation [26,27], our data implicated that this might not be a major mechanism by which prenatal metformin reprograms the hypertension of developmental origin. The gene discussed is PRKAA2; the disease is Hypertension.